We recently published a list of The Best and Worst Dow Stocks for the Next 12 Months. In this article, we are going to take a ...

Feedback notes the proliferation of AI company logos, and agrees with one blogger's claim that many bear a striking ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

Amgen ( NASDAQ: AMGN) expects revenue of $34.3B-$35.7B and non-GAAP EPS of $20.00-$21.20 for full year 2025. A Seeking Alpha ...

Key growth drivers include major biologics' patent expirations and cost-effectiveness, while European market leads with 45.8% share in 2023.Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Biosimilars: ...

Amgen is preparing to release its Q1 2025 earnings, with analysts expecting $4.18 EPS and $8.05 billion in revenue. In its ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

Hancock Whitney Corp shaved off 5.6% of its Amgen holdings during the fourth quarter, selling 2,474 shares but still ...

Amgen will invest $900M to expand its Columbus region biomanufacturing facility, bringing total investment in Central Ohio to ...

Amgen, based in Thousand Oaks, California, first broke ground in New Albany in 2021. Here's how the company plans to expand.

THOUSAND OAKS, Calif., April 25, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $900 million expansion of its ...

Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.